Victoza lawsuits are being filed because patients allege that the drug manufacturer failed to provide adequate warnings about serious health risks associated with the medication
Not because they do the same thing
American association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update
Earlier this month, Novo Nordisk slashed Wegovy prices by up to 37% across dosages, a crucial strategic move by the drug major that has so far been unable to see a significant uptick vis-a-vis rival Mounjaro (tirzepatide) from Eli Lilly in the sale of its weight-loss injectable in India
de Arce KP, Ribic A, Chowdhury D, Watters K, Thompson GJ, Sanganahalli BG, et al
35% of users reported no side effects